Stopping GLP-1 drugs can quickly erase cardiovascular benefits
March 18, 2026
March 18, 2026
ST. LOUIS, Missouri, March 18 -- The Washington University School of Medicine posted the following news release:
* * *
Stopping GLP-1 drugs can quickly erase cardiovascular benefits
*
Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular benefits. However, when patients stop ta . . .
* * *
Stopping GLP-1 drugs can quickly erase cardiovascular benefits
*
Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular benefits. However, when patients stop ta . . .